LQDA 240816 10.00C (LQDA240816C10000) Stock Options, News & Quotes

US OptionsDetailed Quotes

LQDA240816C10000

Watchlist

2.10
+0.12+6.06%

15min DelayTrading Jul 22 13:09 ET

2.10High2.02Low

Intraday

5D
Daily

News

Institutional Investors in Liquidia Corporation (NASDAQ:LQDA) See US$89m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Key Insights Institutions' substantial holdings in Liquidia implies that they have significant influence over the company's share price The top 7 shareholders own 54% of the company 11% of
Simply Wall StJul 18 13:03 ET
Expert Outlook: Liquidia Through The Eyes Of 5 Analysts
5 analysts have shared their evaluations of Liquidia (NASDAQ:LQDA) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings,
BenzingaJul 18 08:07 ET
Liquidia Price Target Maintained With a $28.00/Share by Needham
Liquidia Price Target Maintained With a $28.00/Share by
Dow JonesJul 18 05:39 ET
Express News | Needham Reiterates Buy on Liquidia, Maintains $28 Price Target
BenzingaJul 18 05:29 ET
Needham Maintains Liquidia(LQDA.US) With Buy Rating, Maintains Target Price $28
Needham analyst Serge Belanger maintains $Liquidia(LQDA.US)$ with a buy rating, and maintains the target price at $28.According to TipRanks data, the analyst has a success rate of 44.6% and a total
Moomoo NewsJul 17 17:32 ET · Ratings
Buy Rating Affirmed Amid Legal Challenges and FDA Approval Prospects for Liquidia Technologies
TipRanksJul 17 16:35 ET

Comments

B00GIE

Jul 5 16:27

$Liquidia(LQDA.US)$ 13.50

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics(UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Liquidia(LQDA.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$MorphoSys(MOR.US)$ Phase 3
$Immunocore(IMCR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$Capricor Therapeutics(CAPR.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3...

Meltyy

Apr 30 04:09

🔔 FDA PDUFA Update…

📣 3 PDUFAs left in April! See summary 👇
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US)$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US)$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US)$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US)$ : CRL 4/22 🙁
⚠...

Meltyy

Apr 9 10:48

FDA PDUFA Update…

🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$Legend Biotech(LEGN.US)$ & $Johnson & Johnson(JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$AstraZeneca(AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US)$ & $Bristol-Myers Squibb(BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$Vanda Pharmaceuticals(VNDA.US)$...

Meltyy

Apr 1 03:25

PDUFA Calendar-April

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Vanda Pharmaceuticals(VNDA.US)$ $Legend Biotech(LEGN.US)$ $Supernus Pharmaceuticals(SUPN.US)$ $ImmunityBio(IBRX.US)$ $Aquestive Therapeutics(AQST.US)$ $X4 Pharmaceuticals(XFOR.US)$ $Liquidia(LQDA.US)$ $Neurocrine Biosciences(NBIX.US)$ $Moderna(MRNA.US)$ $Day One Biopharmaceuticals(DAWN.US)$
...